CTR 536/2014: First approvals and our experience with CTIS (Part 3)

CTR 536/2014: Where do we come from and where do we go? (Part I)

GLP-1 agonists: an option for NAFLD?

EU Clinical Trials Regulation (EU-CTR) enters application on 31 January 2022

Reporting of study results: a challenge?

Type 1 Diabetes and mild cognitive impairment

Current developments in approaches to bridging studies

Update on Brexit: Impact on future and current clinical trials in Germany

New timelines for the EU Portal and implementation of the EU Clinical Trial Regulation

CGM in pregnant women with type 1 diabetes